Antiseizure drugs and women: Challenges with contraception and pregnancy

Public Health Agency of Canada. Epilepsy in Canada. Canadian Chronic Diseases Surveillance System (CCDSS). September 2017. Available: https://www.canada.ca/en/public-health/services/publications/diseases-conditions/epilepsy.html (accessed Nov. 4, 2019).

Ng R Maxwell CJ Yates EA , et al. Brain disorders in Ontario: prevalence, incidence and costs from health administrative data. Toronto (ON): Institute for Clinical Evaluative Sciences; 2015.

Stephen LJ Harden C Tomson T Brodie MJ . Management of women in epilepsy. Lancet Neurol 2019;18:481-91.

Gooneratne IK Wimalaratna S . Update on management of epilepsy in women for the non-neurologist. Postgrad Med J 2016;92:554-9.

Reimers A Brodtkorb E Sabers A . Interactions between hormonal contraception and antiepileptic drugs: clinical and mechanistic considerations. Seizure 2015;28:66-70.

Schwenkhagen AM Stodieck SRG . Which contraception for women with epilepsy. Seizure 2008;17:145-50.

Harden CL Hopps J Ting TY , et al. Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes. Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009;73:133-41.

Harden CL Pennell PB Koppel BS , et al. Practice parameter update: management issues for women with epilepsy—focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding. Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009;73:142-9.

Reddy DS . Clinical pharmacokinetic interactions between antiepileptic drugs and hormonal contraceptives. Expert Rev Clin Pharmacol 2010;3:183-92.

The Epilepsy Implementation Task Force and Provincial Neurosurgery Ontario. Provincial guidelines for the management of epilepsy in adults and children. Toronto (ON): Critical Care Services Ontario; 2015.

Gooneratne I Wimalaratna M Ranaweera P Wilamaratna S . Contraception advice for women with epilepsy. BMJ 2017;357:j2010.

Tomson T Battino D . Teratogenic effects of antiepileptic drugs. Lancet Neurol 2012;11:803-13.

Wieck A Jones S . Dangers of valproate in pregnancy. BMJ 2018;361:k1609.

Bhakta J Bainbridge J Borgelt L . Teratogenic medications and concurrent contraceptive use in women of childbearing ability with epilepsy. Epilepsy Behav 2015;52:212-7.

Abe A Hamada H Tamada T Obata-Yasuoka M Minakami H Yoshikawa H . Impact of planning of pregnancy in women with epilepsy on seizure control during pregnancy and on maternal and neonatal outcomes. Seizure 2014;23:112-6.

Borgelt L Hart F Bainbridge J . Epilepsy during pregnancy: focus on management strategies. Int J Womens Health 2016;8:505-517.

Harden CL Hopp J Ting TY , et al. Practice parameter update: management issues for women with epilepsy—focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency. Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009;73:126-32.

Brodtkorb E Reimers A . Seizure control and pharmacokinetics of antiepileptic drugs in pregnancy women with epilepsy. Seizure 2008;12:160-5.

Davanzo R Bo SD Bua J Copertino M Zanelli E Matarazzo L . Antiepileptic drugs and breastfeeding. Ital J Pediatr 2013;39:50.